Cardiomiopatias

Arquivos Brasileiros de Cardiologia

Volumn 71, Issue 2, 1998, Pages 95-107

  Albanesi Fo, Francisco Manes ^a  

^a NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTIARRHYTHMIC AGENT; BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE; DIURETIC AGENT; LACTATE DEHYDROGENASE; VASODILATOR AGENT; VIRUS RNA;

AUTOSOMAL DOMINANT INHERITANCE; CARDIOMYOPLASTY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; COXSACKIE VIRUS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART DILATATION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEMODYNAMICS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NUCLEAR MAGNETIC RESONANCE; PATHOGENESIS; PROGNOSIS; RESTRICTIVE CARDIOMYOPATHY; REVIEW; THORAX RADIOGRAPHY; VIRUS INFECTION;

ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOMYOPATHY, RESTRICTIVE; HUMANS; PROGNOSIS;

EID: 0032440099     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0066-782X1998000800002     Document Type: Article

References (94)

1. Report of World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Br Heart J 1980; 44: 672-3.
2. Report of 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996; 93: 841-1.
3. Bagger JP, Baandrup U, Rasmussen K, Moller M, Vesterland T-Cardiomyopathy in western Denmark. Br Heart J 1984; 52: 327-31.
4. Williams DG, Olsen EGJ - Prevalence of overt dilated cardiomyopathy in two regions of England. Br Heart J 1985; 54: 153-5.
5. Gillum RF - Idiopathic cardiomyopathy in the United States. Am Heart J 1986; 111: 752-5.
6. Coughlin SS, Szklo M, Baughman K, Pearson TA - The epidemiology of idiopathic dilated cardiomyopathy in a biracial community. Am J Epidemiol 1990; 131: 48-56.
7. Codd MB, Sugrue DD, Gersh BJ, Melton LJ- Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted Country, Minnesota, 1975-1984. Circulation 1989; 80: 564-72.
8. th ed. Philadelphia: WB Saunders, 1997: 1404-14.
9. nd ed. London: Saunders, 1996: 489-505.
10. rd ed. Missouri: Mosby - Year Book, 1996: 636-71.
11. Kasper EK, Agema WRP, Hutchins GM et al - The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol 1994; 23: 586-90.
12. Michels VV, Moll PP, Miller FA et al -The frequency of familial dilated cardiomyopathy in series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 1992; 326: 77-82.
13. Mestroni L, Miani D, Di Lenarda et al - Clinical and pathologic study of familial dilated cardiomyopathy. Am J Cardiol 1990; 65: 1449-53.
14. Berko BA, Swift M - X-linked dilated cardiomyopathy. N Engl J Med 1987; 316: 1186-91.
15. Zachara E, Caforio AL, Carboni GP et al - Familial aggregation of idiopathic dilated cardiomyopathy. Clinical features and pedigree analysis in 14 families. Br Heart J 1993; 69: 129-35.
16. McKenna WJ - Clinical genetics of dilated cardiomyopathy. Herz 1994; 19: 91-6.
17. Durand JB, Bachinski LL, Bieling BS, Czernuszewicz GZ et al - Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32 Circulation 1995; 92: 3387-9.
18. Raynolds MV, Bristow MR, Bush EW et al - Angiotensin-converting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1073-5.
19. Zimmerman E, Chwojnik A, Lerman J - Idiopathic dilated cardiomyopathy with or without mild dilatation of the cardiac ventricles in multiple family members. Am J Cardiol 1992; 69: 129-35.
20. Kass S, MacRae C, Graber HL et al - A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nature Genet 1994; 7: 546-51.
21. Editorials - Dilated cardiomyopathy and enteroviruses. Lancet 1990; 336: 971-3.
22. Woodruff JF - Viral myocarditis. A review. Am J Pathol 1980; 101: 427-79.
23. Kishimoto C, Kurnick JT, Fallon JT, Crumpacker CS, Abelmann NH - Characteristics of lymphocytes cultured from murine viral myocarditis specimens. A preliminary and technical report. J Am Coll Cardiol 1989; 14: 799-802.
24. Hare JM - The etiologic basis of heart failure. In: Braunwald E (ed) - Atlas of heart failure. Vol. IV Heart Failure - Cardiac Function and Dysfunction. St Louis: Mosby, 1995; 3.1: 3.23.
25. Jin O, Sole MJ, Butany JW et al - Detection of entrovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polimerase chain reaction. Circulation 1990; 82: 8.
26. Bowles NE, Ohlesen EGJ, Richardson PJ, Archard LC- Detection of coxsachie B virus-specific RNA sequences in myocarditis and dilated cardiomyopathy. Lancet 1986; 1: 1120-2.
27. Grasso M, Arbusti E, Silini E et al - Search for coxsachie B3 RNA in idiopathic dilated cardiomyopathy using gene amplification by polimerase chain reaction. Am J Cardiol 1992; 69: 658-64.
28. Kandolf R, Ameis D, Kirschener P, Canu A, Hofschneider PIH - In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization, in approach to the diagnosis of viral heart disease. Proc Nat Acad Sci USA 1985; 82: 4818-22.
29. Archard LC, Bowles NE, Cunningham L et al - Molecular probes for detection of persisting enterovirus infection of human heart and their prognostic value. Eur Heart J 1991; 12(suppl D): 56-9.
30. Schultheiss HP, Kühl U - Cardiomyopathies and specific heart muscle diseases. In: Poole-Wilson PA, (ed) - Heart Failure. New York: Churchill Livingstone, 1997: 423-38.
31. th ed. New York: McGraw-Hill, 1994: 1609-19.
32. a ed. São Paulo: Sarvier, 1995: 89-105.
33. a ed. Rio de Janeiro: de Janeiro: Atheneu, 1994: 370-7.
34. nd ed. Massachusetts: Blackwell Science, 1996: 375-84.
35. Task Force of the European Society of Cardiology, in Collaboration with the Association of European Paediatrics Cardiologists - The clinical role of magnetic resonance in cardiovascular disease. Eur Heart J 1998; 19: 19-39.
36. Doherty NE, Fujita N, Caputo GR, Higgins CB - Measurement of right ventricular mass in normal and dilated cardiomyopathic ventricles using cine magnetic resonance imaging. Am J Cardiol 1992; 69: 1223-8.
37. rd ed, Missouri: Mosby - Year Book, 1996: 672-88.
38. The SOLVD Investigators - Effect of enalapril on mortality and development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 1992; 327: 85-9.
39. Kostam MA, Rousseau MF, Kronenberg MW et al - Effects of angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. Circulation 1992; 86: 431-8.
40. st ed. Philadelphia: WB Saunders, 1996: 176-99.
41. Wakabayashi A, Yui Y, Kawai C - A clinical study on thiamin deficiency. Jap Circulation J 1979; 43: 995-9.
42. Yui Y - Furosemide-induced thiamin deficiency. Cardiovasc Res 1980; 12: 537-40.
43. Brady JA, Rock C, Horneffer MR - Thiamin status, diuretic mediations, and the management of congestive heart failure. J Am Diet Assoc 1995; 95: 541-4.
44. Seligmann H, Halkin H, Rauchfleisch S et al - Thiamin deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. Am J Med 1991; 92: 151-5.
45. The Digitalis Investigation Group - The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-34.
46. Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrinson MC, Jolly MK - Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial, PROVED Investigative Group. J Am Coll Cardiol 1993; 22: 955-62.
47. Packer M, Gheorrghiade M, Young JB et al for RADIANCE Study - Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. N Engl J Med 1993; 329: 1-7.
48. Waagstein F, Bristow KS, Camerini F et al - Beneficial effects of metoprolol in dilated idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1141-6.
49. Packer M, Bristow MR, Cohn JN et al - The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-55.
50. Hochleintner M, Heitnagl N, Hörtnagl H, Fridrich L, Gshitzer F - Long-term efficacy of physiologic dual chamber pacing in the treatment of end-stage idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 70: 1320-5.
51. a ed. São Paulo: ABC Artes Gráficas, 1996: 329-50.
52. Randas RJV, Santos JLV, Franzoni M et al - Ventriculectomia parcial: um novo conceito no tratamento cirúrgico de cardiopatias em fase final. Rev Bras Cir Cardiovasc 1996; 66: 1-6.
53. World Health Organization/Council on Geriatric Cardiology Task Force on Heart Failure Education - Concise Guide to the management of heart failure. January 1997.
54. Wynne J, Braunwald E - The cardiomyopathies and myocarditides - hypertrophic cardiomyopathy In: Braunwald E (ed) - Heart Disease - A Textbook of Cardiovascular Medicine, 5th ed. Philadelphia: WB Saunders, 1997: 1414-26.
55. Nishimura RA, Giuliani ER, Brandenburg RO, Danielson GK - Hypertrophic cardiomyopathy In: Giuliani ER et al (ed) - Mayo Clinic Practice of Cardiology, 3rd ed. Missouri, Mosby-Year Book Inc., 1996 : 689-711.
56. McKenna WJ - Hypertrophic cardiomyopathy. In: Jullian DG et al (ed) - Diseases of Heart. 2nd ed. London: WB Sauders, 1996: 506-17.
57. Wigle ED, Sasson Z, Henderson MA, Ruddy TD et al - Hypertrophic cardiomyopathy. The importance of the site and extent of hypertrophy. A Review Prog Cardiovasc Dis 1985; 28: 1-83.
58. th ed. New York: McGraw-Hill, 1994: 1621-35.
59. a ed. São Paulo: Sarvier, 1995: 106-24.
60. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE - Prevalence of hypertrophic cardiomyopathy in general population of young adults: echocardiographic analysis of 4111 subjects in CARDIA Study. Circulation 1995; 92: 785-9.
61. Arteaga E, Mady C - Cardiomiopatia hipertrófica: características clínicas, métodos diagnósticos e história natural. Arq Bras Cardiol 1996; 66: 115-7.
62. Sakamoto T, Tei C, Murayama M et al - Giant T wave inversion as manifestation of asymetrical hypertrophy of the left ventricle. Jpn Heart J 1976; 17: 611-29.
63. Yamaguchi H, Ishimura T, Nishiyama S et al - Hypertrophic nonobstrutive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol 1979; 44: 401-12.
64. o FM - Cardiomiopatia hipertrófica apical. Arq Bras Cardiol 1966; 66: 91-5.
65. atkins H - Multiple disease genes cause hypertrophic cardiomyopathy. Br Heart J 1994; 72(sppl S): S4-S9.
66. pirito P, Bellone P - Natural history of hypertrophic cardiomyopathy. Br Heart J 1994; 72(suppl S): S10-S12.
67. o FM, Castier, MB, Soares, JP - Ovalor da biópsia endomiocárdica no diagnóstico diferencial entre endomiocardiofibrose do ventricule esquerdo e a cardiomiopatia hipertrófica apical. Rev Soc Cardiol ERJ 1994; 7: 78-82.
68. o FM, Castier MB, Diamant JDA, Lopes JS, Lopes AS, Ginefra P -Cardiomiopatia hipertrófica apical acometendo o ventrículo direito. Arq Bras Cardiol 1997; 68: 119-24.
69. Spirito P, Seidman CE, McKenna WJ, Maron BJ - The management of hypertrophic cardiomyopathy. N Engl J Med 1997; 336: 775-85.
70. Wigle ED, Rakowski H, Kimball BP, Williams WG - Hypertrophic cardiomyopathy clinical spectrum and treatment. Circulation 1995; 92: 1680-92.
71. Cannan CR , Reeder GS, Bailey KR, Melton LJ et al - Natural history of hypertrophic eardiomyopathy: a population-based study, 1976 trough 1990. Circulation 1995; 92: 2488-95.
72. Maron BJ, Cecchi F, McKenna WJ - Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy. Br Heart J 1994; 72(suppl-S): S13-S18.
73. Sherrid MV, Pearle G, Gunsburg DZ - Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy. Circulation 1998; 97: 41-7.
74. Fananapazir L, Epistein ND, Curiel RV et al - Long term results of dual chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Circulation 1994; 90: 2731-42.
75. Fananapazir L, McAreavey D - Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms. J Am Coll Cardiol 1998; 31: 259-64.
76. a ed. New York: Churchill Livingstone, 1996: 185-7.
77. Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S - Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998; 31: 252-8.
78. Schulte HD, Bircks W, Lösse B, Godehardt EAJ, Schwartzkopff B - Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy: late results up to twenty-five years. J Thorac Cardiovas Surg 1993; 106: 709-17.
79. Heric B, Lytle BW, Miller DP, Rosenkranz ER, Lever HM, Cosgrove DM - Surgical management of obstructive hypertrophic cardiomyopathy: early and late results. J Thorac Cardiovas Surg 1995; 110: 195-208.
80. Robbins RC, Stinson EB - Long-term results of left ventricular myotomy and myectomy for obstructive cardiomyopathy. J Thorac Cardiovas Surg 1996; 111: 586-94.
81. McCully RB, Nishimura RA, Tajik AJ, Schaff HV, Danielson GK - Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation 1996; 94: 467-71.
82. th ed. Missouri: Mosby-Year Book, 1997: 712-26.
83. th ed. Philadelphia:, WB Saunders, 1997: 1426-58.
84. Mc Kenna WJ, Thiene G, Nava A, et al - Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and the Scientific Council on Cardiomyopathies of International Society and Federation of Cardiology. Br Heart J 1994; 71: 215-8.
85. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N - Right ventricular cardiomyopathies and sudden death in young people. N Engl J Med 1988; 318; 129-33.
86. Maia IG, Sá RMS, Bassan R et al - Displasia ventricular direita arritmogênica. Aspectos clínicos e terapêuticos. Arq Bras Cardiol 1991; 57: 97-103.
87. Casolo GC, Poggesi L, Boddi M et al - ECG-gated magnetic resonance imaging in right ventricular dysplasia. Am Heart J 1987; 113: 1245-8.
88. Blake LM, Scheinman MM, Higgins CB - MR features of arrhythogenic right ventricular dysplasia. Am J Roentgenol 1994; 162: 809-12.
89. Dougherty AH, Naccarelli GV, Gray EL, Hicks CH, Goldestein RA - Congestive heart failure with normal systolic function. Am J Cardiol 1984; 54: 778-82.
90. Soufer R, Wohlgelernter D, Vita NA et al - Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol 1985; 55: 1032-6.
91. Takarada A, Kurogane H, Minamiji T et al - Congestive heart failure in elderly-echocardiographic insights. Jpn Circ J 1992; 56: 527-34.
92. Topol EJ, Trail TA, Fortuin NJ - Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med 1985; 312: 277-83.
93. Lewis JF, Maron BJ - Clinical and morphologic expression of hypertrophic cardiomyopathy in patients≥65 years of age. Am J Cardiol 1994; 73: 1105-10.
94. Fay WP, Talierio CP, Ilstrup DM, Tajik AJ, Gersh BJ - Natural history of hypertrophic cardiomyopathy in the elderly. J Am Coll Cardiol 1990; 16: 821-6.